Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89101-89150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06980818
Oral Microbiota Dysbiosis in IBD
N/AActive, not recruiting
130 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05182229
Comparing Two Ways to Manage Head and Neck Lymphedema
NARecruiting
300 participants
Started: Mar 11, 2022 · Completed: Nov 30, 2026
2 conditions2 sponsors6 locations
NCT04864054
T-Cell Therapy (ECT204) in Adults With Advanced HCC
PHASE2Recruiting
20 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2027
4 conditions1 sponsor5 locations
NCT05360212
Anatomy-based Fitting in Cochear Implant Users
NARecruiting
30 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05699083
Outcomes After Weight Loss Surgery in Low-Risk Patients
NARecruiting
20 participants
Started: Mar 11, 2022 · Completed: Jan 12, 2026
2 conditions1 sponsor1 location
NCT05206773
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
PHASE3Active, not recruiting
122 participants
Started: Mar 11, 2022 · Completed: Jan 4, 2027
1 condition1 sponsor58 locations
NCT05147181
A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland
N/AActive, not recruiting
48 participants
Started: Mar 11, 2022 · Completed: Mar 28, 2026
1 condition1 sponsor14 locations
NCT05143164
Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients
NAActive, not recruiting
60 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05330078
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
EARLY_PHASE1Active, not recruiting
10 participants
Started: Mar 11, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor1 location
NCT05138614
Supporting Treatment Access and Recovery in COD
NARecruiting
1,000 participants
Started: Mar 11, 2022 · Completed: Aug 31, 2026
2 conditions5 sponsors5 locations
NCT04852744
NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER
NARecruiting
99 participants
Started: Mar 11, 2022 · Completed: Jun 1, 2028
1 condition7 sponsors1 location
NCT06702787
Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry
N/AEnrolling by invitation
1,500 participants
Started: Mar 11, 2022 · Completed: Sep 11, 2025
4 conditions1 sponsor1 location
NCT05193591
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
N/ARecruiting
30 participants
Started: Mar 11, 2022 · Completed: Sep 10, 2025
1 condition2 sponsors2 locations
NCT05241457
Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.
N/ARecruiting
120 participants
Started: Mar 11, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05315791
Clinical Application Strategies of Maxillary Sinus Buccal Bony Window
NARecruiting
60 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05284877
The Organ Transplant Recipient HPV and Skin Cancer Study
N/ARecruiting
1,500 participants
Started: Mar 10, 2022 · Completed: Mar 31, 2043
7 conditions6 sponsors3 locations
NCT05557123
Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)
NARecruiting
1,042 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05213338
Wear-documentation and Orthodontic Appliance Compliance
NAActive, not recruiting
52 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05791916
Novel Biomarkers in Patients With Acute Myocardial Infarction
N/ARecruiting
500 participants
Started: Mar 10, 2022 · Completed: Feb 28, 2025
4 conditions1 sponsor2 locations
NCT05321225
The Level of Blood Brain Barrier Damage Biomarker in Acute Ischemic Stroke
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05100862
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
PHASE3Recruiting
780 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2030
2 conditions1 sponsor259 locations
NCT05344443
Lemborexant Shift Work Treatment Study
PHASE4Recruiting
45 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04530799
Prospective Observational Trial of IAPA
N/ARecruiting
350 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor12 locations
NCT05201248
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Mar 10, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors18 locations
NCT04577859
Esophageal Protection Study: A Multicenter Study
NAActive, not recruiting
152 participants
Started: Mar 10, 2022 · Completed: May 31, 2026
3 conditions6 sponsors6 locations
NCT05205499
A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
NAActive, not recruiting
1,059 participants
Started: Mar 10, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT04265950
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial
PHASE4Active, not recruiting
97 participants
Started: Mar 10, 2022 · Completed: Jul 31, 2026
1 condition5 sponsors3 locations
NCT04836429
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
PHASE1Active, not recruiting
5 participants
Started: Mar 10, 2022 · Completed: Jan 3, 2026
2 conditions1 sponsor1 location
NCT05131074
Collabree: A Remote Intervention to Improve the Regularity of Medication Intake
NAEnrolling by invitation
180 participants
Started: Mar 10, 2022 · Completed: Nov 30, 2024
2 conditions2 sponsors1 location
NCT04298905
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
NAActive, not recruiting
62 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT04805528
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
NARecruiting
75 participants
Started: Mar 10, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05468307
Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic Tumors
EARLY_PHASE1Recruiting
50 participants
Started: Mar 10, 2022 · Completed: Mar 10, 2025
4 conditions2 sponsors1 location
NCT06743438
Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
PHASE4Active, not recruiting
640 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT05315700
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
PHASE1/PHASE2Recruiting
350 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor42 locations
NCT05237375
MIDWIZE - Strengthening Midwives
N/ARecruiting
1,000 participants
Started: Mar 10, 2022 · Completed: Sep 1, 2025
1 condition2 sponsors4 locations
NCT05096182
Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study
N/AActive, not recruiting
10 participants
Started: Mar 10, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05174169
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2/PHASE3Recruiting
1,912 participants
Started: Mar 10, 2022 · Completed: Mar 10, 2030
1 condition3 sponsors1005 locations
NCT04904536
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
PHASE3Active, not recruiting
190 participants
Started: Mar 10, 2022 · Completed: Jul 30, 2025
1 condition7 sponsors1 location
NCT05189470
Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers
NAActive, not recruiting
100 participants
Started: Mar 10, 2022 · Completed: Feb 28, 2025
6 conditions2 sponsors4 locations
NCT04975841
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
NAActive, not recruiting
9 participants
Started: Mar 10, 2022 · Completed: Sep 29, 2025
1 condition1 sponsor1 location
NCT05206084
A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
NAActive, not recruiting
518 participants
Started: Mar 10, 2022 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05287464
International Multicentric Study ARON-1
N/ARecruiting
1,220 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
PHASE1Recruiting
170 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
9 conditions1 sponsor10 locations
NCT05250505
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NAActive, not recruiting
30 participants
Started: Mar 10, 2022 · Completed: Apr 30, 2027
2 conditions4 sponsors1 location
NCT05615545
Cryoablation for Advanced Bone and Soft Tissue Tumors
N/ARecruiting
30 participants
Started: Mar 10, 2022 · Completed: Oct 28, 2024
2 conditions1 sponsor1 location
NCT05209763
Standard vs Intensive Rehabilitation and Nutrition Regimen for Inpatients at the ICU
NARecruiting
500 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04927533
The Ronnie Gardiner Method Effectiveness Study
NARecruiting
120 participants
Started: Mar 10, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05394714
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
PHASE1Recruiting
18 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04711824
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
PHASE1/PHASE2Recruiting
41 participants
Started: Mar 9, 2022 · Completed: Nov 30, 2026
2 conditions3 sponsors7 locations